Patent · US Active

Natural combination hormone replacement formulations and therapies

US10806740B2 · kind B2 · utility

10Cited by
578References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 10, 2014
Grant dateOct 20, 2020
Priority date—
Expiry dateOct 10, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/565
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutical formulations for co-administering estradiol and progesterone are provided herein. In some embodiments, the formulation comprises solubilized estradiol, suspended progesterone, and a medium chain (C6-C12) oil.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.